[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Precision Peptide Company Inc (BPC.CN)

Precision Peptide Company Inc (BPC.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])

Fundamentals

See More
  • Market Capitalization, $K 22,116
  • Shares Outstanding, K 46,560
  • Annual Sales, $ 50 K
  • Annual Income, $ -4,527 K
  • EBIT $ N/A
  • EBITDA $ N/A
  • 60-Month Beta 2.00
  • Price/Sales 159.38
  • Price/Cash Flow N/A
  • Price/Book 82.26

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.3600 +37.50%
on 05/20/26
0.5300 -6.60%
on 06/02/26
+0.0250 (+5.32%)
since 05/08/26
3-Month
0.2900 +70.69%
on 03/11/26
0.5700 -13.16%
on 05/05/26
+0.1650 (+50.00%)
since 03/10/26
52-Week
0.1750 +182.86%
on 01/28/26
0.5700 -13.16%
on 05/05/26
+0.1650 (+50.00%)
since 06/10/25

Most Recent Stories

More News
The Precision Peptide Company Establishes Compliant U.S. Peptide Access with Telehealth and Prescription Infrastructure Partnership

HighlightsSigned an agreement with a U.S.-based prescription telehealth and infrastructure partner to support compliant prescribing, fulfillment, and delivery of the Company's peptide productsBuilds on...

BPC.CN : 0.4950 (+4.21%)
PNGAF : 0.3400 (+3.66%)
The Precision Peptide Company Inc. Announces Extension of Investor Relations Agreement with Emerging Markets Consulting, LLC

Vancouver, British Columbia--(Newsfile Corp. - June 5, 2026) - The Precision Peptide Company (CSE: BPC) (OTCQB: PNGAF) (the "Company" or "BPC"), is pleased to announce that, further to its news release...

BPC.CN : 0.4950 (+4.21%)
PNGAF : 0.3400 (+3.66%)
The Precision Peptide Company Inc. Signs Agreement with U.S.-Based 503A Sterile Compounding Pharmacy - Peptides to be 100% Compounded in the United States

HighlightsExecuted compounding agreement with a U.S.-based 503A sterile compounding pharmacy partnerCompounding activities under the agreement expected to commence on Monday, June 1, 2026All peptides under...

BPC.CN : 0.4950 (+4.21%)
PNGAF : 0.3400 (+3.66%)
The Precision Peptide Company to Exhibit as the Only Peptide Company at Dave Asprey's BEYOND Conference in Austin, Texas

HighlightsOnly peptide company exhibiting at BEYOND 2026, Dave Asprey's flagship biohacking, longevity, and consciousness conferenceThree immersive days in Austin, Texas — May 27-29, 20265,000+ attendees,...

BPC.CN : 0.4950 (+4.21%)
PNGAF : 0.3400 (+3.66%)
The Precision Peptide Company Inc. Places Order for 20,000 BPC-157 Transdermal Patches

HighlightsOrder placed for 20,000 units of the Company's lead product candidate, a needle-free BPC-157 transdermal patch, in preparation for commercial releaseInitial commercial release of the BPC-157...

BPC.CN : 0.4950 (+4.21%)
PNGAF : 0.3400 (+3.66%)
Peptide-Based Health Industry Positioned for Explosive Long-Term Growth Across Global Wellness Markets

EQNX::TICKER_START (OTCQB:PNGAF),(CSE:BPC),(NYSE:MMA),(NYSE:NVO),(NYSE:HIMS),(NYSE:LLY) EQNX::TICKER_END

MMA : 0.7950 (-1.85%)
BPC.CN : 0.4950 (+4.21%)
PNGAF : 0.3400 (+3.66%)
NVO : 42.81 (+1.47%)
HIMS : 27.78 (-4.14%)
LLY : 1,136.37 (-0.73%)
Peptide-Based Health Industry Positioned for Explosive Long-Term Growth Across Global Wellness Markets

NEW YORK, May 21, 2026 (GLOBE NEWSWIRE) -- Market News Updates News Commentary - The market for peptide-based health and performance products has been growing fast as more consumers focus on fitness,...

MMA : 0.7950 (-1.85%)
BPC.CN : 0.4950 (+4.21%)
PNGAF : 0.3400 (+3.66%)
NVO : 42.81 (+1.47%)
HIMS : 27.78 (-4.14%)
LLY : 1,136.37 (-0.73%)
The Precision Peptide Company (BPC) Expands on Exclusive 50/50 Revenue Share Peptide Partnership with MMA.INC (MMA)

Exclusive Agreement Gives Precision Direct Commercial Access to MMA.INC's Global Combat Sports Ecosystem, Backed by Strategic Advisors Conor McGregor and Donald Trump Jr., Cofounder John Kavanagh and Board...

BPC.CN : 0.4950 (+4.21%)
PNGAF : 0.3400 (+3.66%)
The Precision Peptide Company (BPC) Lead Product Achieves 95.5% Purity in Independent Lab Testing, Clearing the Industry Benchmark and Advancing Toward Commercial Launch

HighlightsThe BPC-157 patch is a wearable, needle-free product, designed to remove the injection barrier that has historically limited consumer adoption of peptide productsResults support The Precision...

BPC.CN : 0.4950 (+4.21%)
PNGAF : 0.3400 (+3.66%)
The Precision Peptide Company's Chief Scientific Officer Justin Kirkland to Be Featured on The Human Upgrade with Dave Asprey

Vancouver, British Columbia--(Newsfile Corp. - May 14, 2026) - The Precision Peptide Company (CSE: BPC) (OTCQB: PNGAF) (the "Company" or "BPC"), a publicly traded wellness company focused on advanced peptide...

BPC.CN : 0.4950 (+4.21%)
PNGAF : 0.3400 (+3.66%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

The Precision Peptide Co Inc is a food manufacturer and distributor of nutritional supplements, functional snacks, natural foods, peptides, and natural personal care products. The company offers end-to-end services from formulation and ingredient sourcing to final packaging and fulfillment. The Company...

See More

Key Turning Points

3rd Resistance Point 0.5633
2nd Resistance Point 0.5317
1st Resistance Point 0.5133
Last Price 0.4950
1st Support Level 0.4633
2nd Support Level 0.4317
3rd Support Level 0.4133

See More

52-Week High 0.5700
Last Price 0.4950
Fibonacci 61.8% 0.4191
Fibonacci 50% 0.3725
Fibonacci 38.2% 0.3259
52-Week Low 0.1750

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.